How a small biotech company used data from an observational research study to increase prescriber and payer confidence and differentiate from the market leader.
How a well-crafted real-world comparative effectiveness study helped a second-to-market product remove formulary hurdles and reach parity access to market leader.
How a proprietary patient-identification tool helped a small biotech company improve health system engagement.
How patient preferences insights were effectively leveraged to inform regulatory and payer approval in a crowded market.